SLEEVE GASTRECTOMY TO CORRECT OBESITY AND ASSOCIATED CO-MORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Obesity has become a serious health problem and it is a major risk factor for the development of insulin resistance and type 2 diabetes mellitus (T2DM). Laparoscopic sleeve gastrectomy (LSG) has revealed to be effective for achieving weight loss and a potential competitor with other operations. The aim of this study is to evaluate weight loss and the reversibility of associated comorbidities in obese T2DM patients, one and three months after LSG. Data collected between January 1st – June 30th 2011 from 23 subjects with obesity and T2DM were analyzed retrospectively. The following parameters recorded before, one and three months after surgery were compared: body mass index (BMI), fasting plasma glucose, lipid profile, arterial blood pressure, hypoglycemic drugs, antihypertensive and hypolipidemic drugs. Mean BMI decreased from 45.17 ± 8.342kg/m² to 39 ± 6.031kg/m² at one month and to 34.91 ± 4.435kg/m² 3 months after surgery. Fasting plasma glucose decreased to 117.87 ± 35.143mg/dl at one month and to 102.22 ± 16.605mg/dl, 3 months after surgery. Following surgery, a full remission of T2DM was achieved in 39% of patients in the first month and in 65% of patients at 3 months. There was also an important improved in lipid profile, blood pressure control and obstructive sleep apnea (OSA). Our study has shown positive early effects of LSG on obese T2DM patients regarding weight loss and obesity - related comorbidities reduction.
Authors and Affiliations
Mihaela Lavinia Moanta, Ilie-Robert Dinu, Maria Mota, C Copăescu
Keywords
Related Articles
- EP ID EP150540
- DOI -
- Views 106
- Downloads 0
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia And Metabolic Syndrome
Introduction and Objective: The aim of this study was to evaluate the relationship between lower urinary tract symptoms (LUTS), benign prostatic hyperplasia, and metabolic syndrome. Methods: 381 patients, over 45 years,...
SUBCUTIS DYSTROPHY IN INSULIN TREATED CIRRHOTIC PATIENT
Insulin injections can induce local dystrophies. Many reasons can be but, the most common is the same area repeatedly injected. Our subject is a 50-year-old man insulin treated, also being under medical survey because of...
THE EPIDEMIOLOGY OF DIABETIC NEUROPATHY
One of the major complications of diabetes mellitus (DM) is represented by the diabetic neuropathy (DN). Different peripheral nerves may be affected through many pathological processes and, therefore, there are many type...
THE RELATIONSHIP BETWEEN sE-Selectin CONCENTRATIONS, MICROALBUMINURIA AND INSULIN-SENSITIVITY IN TYPE 2 DIABETES PATIENTS
The aim of the study was to examine the effects of poor metabolic control on vascular endothelium, expressed by increased soluble E-selectin concentration, microalbuminuria and their relationship with insulin sensitivity...
Maturity Onset Diabetes Of The Young
Maturity-onset diabetes of the young (MODY), named also as “genetic defects of β cell function”, is a type of diabetes mellitus determined by a single mutation of a single gene. There are nine known genes that lead to th...